Eco R1 Capital, LLC Allakos Inc. Transaction History
Eco R1 Capital, LLC
- $1.27 Billion
- Q1 2025
Shares
2 transactions
Others Institutions Holding ALLK
# of Institutions
39Shares Held
50.6MCall Options Held
71.5KPut Options Held
19.8K-
Bvf Inc San Francisco, CA16.6MShares$5.46 Million0.17% of portfolio
-
Tang Capital Management LLC San Diego, CA8.69MShares$2.87 Million0.13% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.23MShares$2.39 Million0.06% of portfolio
-
Nea Management Company, LLC Timonium, MD6.15MShares$2.03 Million0.13% of portfolio
-
Logos Global Management LP San Francisco, CA2.9MShares$957,0000.13% of portfolio
About Allakos Inc.
- Ticker ALLK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 84,726,096
- Market Cap $28M
- Description
- Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...